Thrombus Formation during Percutaneous Closure of an Atrial Septal Defect with an Amplatzer Septal Occluder

Yorgun H., CANPOLAT U., Kaya E. B., Aytemir K., Oto A.

TEXAS HEART INSTITUTE JOURNAL, vol.38, no.4, pp.427-430, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 38 Issue: 4
  • Publication Date: 2011
  • Journal Name: TEXAS HEART INSTITUTE JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.427-430
  • Keywords: Anticoagulants/therapeutic use, blood coagulation/drug effects, echocardiography, transesophageal, heart catheterization/adverse effects, heart septal defects, atrial/blood/therapy, heparin/therapeutic use, prosthesis implantation/adverse effects/instrumentation, septal occluder device, thrombosis/drug therapy/etiology/prevention & control/ultrasonography, treatment outcome, PATENT FORAMEN OVALE, TRANSCATHETER CLOSURE, PLATELET, DEVICE, ACTIVATION
  • Hacettepe University Affiliated: Yes

Abstract

Percutaneous closure of an ostium secundum-type atrial septal defect is typically a safe and effective therapeutic option in the presence of significant shunting or paradoxical embolism. Infrequently, however, periprocedural sequelae occur.